Abstract: Efficacy and Safety of N1539, Intravenous Meloxicam, in a Phase 3 Study of Subjects with Moderate to Severe Pain Following Abdominoplasty by Matthew Bindewald, MD, Sonia Singla, DO, David Leiman, MD, Barr Baynton, MD, Harold S. Minkowitz, MD, Stewart McCallum, MD, Randall Mack, BS, Rosemary Keller, PhD, Alex Freyer, PharmD, Wei Du, PhD

Get full text